E. Coli Minc - Search News

Sanofi, Escherichia coli and J&J

J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.

Bloomberg L.P. · 2d

Sanofi Ends Trial for E. Coli Shot and Takes a $250 Million Hit

Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an invasive form of the digestive pathogen E. coli.

Reuters on MSN · 1d

J&J, Sanofi stop E.coli vaccine trial due to low effectiveness

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the companies said on Thursday.

MarketWatch · 2d

Sanofi: Review Determined Vaccine Candidate for Extraintestinal Pathogenic E. Coli Not Sufficiently Effective

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top

1don MSN

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results

Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli ...

McDonald's Sales Take a Hit After E. Coli Outbreak

McDonald's U.S. sales declined in the fourth quarter of 2024 following an E. coli outbreak linked to its Quarter Pounder ...

Press Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...

McDonald's posts biggest US sales decline in nearly five years

McDonald's posted its biggest US sales decline in nearly five years on Monday (Feb 10). Demand took a hit from a brief E.coli outbreak, while diners also proved cautious spenders. Comparable sales in ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results